Bone Void Filler Market
Bone Void Filler Market Study by Demineralized Bones, Calcium Sulphate, Calcium Phosphate, and Tri Calcium Phosphate for Hospitals, Ambulatory Surgical Centers, and Clinics from 2024 to 2034
Analysis of Bone Void Filler Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Bone Void Filler Market Outlook (2024 to 2034)
The global bone void filler market is pegged at a valuation of US$ 3.58 billion in 2024 and is set to reach US$ 6.03 billion by the end of 2034. Global demand for bone void fillers is forecasted to rise at a 5.3% CAGR from 2024 to 2034.
Bone void fillers are mostly biological materials that are used to fill in gaps found in the human skeletal system. Bone fillers provide stability and improve the bone regeneration process, which is why their use in different orthopedic applications is projected to increase steadily over the coming years.
Surging incidence of trauma cases, high prevalence of bone disorders, expanding geriatric population, and increasing availability of advanced bone void fillers are projected to be key bone void filler market trends. The growing adoption of synthetic bone void fillers is also forecasted to boost demand for orthopedic devices, orthopedic implants, orthopedic braces, and other orthopedic equipment going forward.
Rising preference for minimally invasive surgeries among patients and faster recovery times associated with the use of bone void fillers in orthopedic surgeries are also estimated to enlarge the bone void filler market size on a global level through 2034.
To avoid the risk of infection, bone void filler manufacturers are focusing on the development and launch of antibiotic-eluting bone fillers. Increasing investments in orthopedic research and growing demand for bone regenerative products are also forecasted to support bone void filler market growth over the next 10 years.
- In June 2023, BONESUPPORT, a renowned biotech company based in Sweden, announced the launch of its next-generation antibiotic-eluting bone graft substitute. The new CERAMENT G kit was redesigned to improve its ease of use and shelf life as well.
Report Attributes | Details |
---|---|
Bone Void Filler Market Size (2024E) | US$ 3.58 Billion |
Projected Market Value (2034F) | US$ 6.03 Billion |
Global Market Growth Rate (2024 to 2034) | 5.3% CAGR |
East Asia Market Value (2024E) | US$ 515 Million |
North America Market Share (2034F) | 41.8% |
China Market Growth Rate (2024 to 2034) | 8.6% CAGR |
Sales of Demineralized Bone Void Fillers (2024E) | US$ 1.44 Billion |
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What’s Hindering the Success of Bone Void Filler Manufacturers?
“High Cost of Orthopedic Surgeries and Risk of Improper Filler Placement”
Orthopedic surgeries are expensive by themselves, and given the requirement of bone void fillers, the cost adds up making it even heavier on the pockets of patients. Clinical restrictions associated with the use of bone void fillers also impact their penetration, which results in a reduced success rate of the procedure.
Other concerns associated with low penetration are filler rupture, little to no bone growth, and infection of bone and tissues surrounding it. All of the aforementioned factors are projected to inhibit bone void filler sales and also decrease the chances of acceptance of bone void filler procedures among patients in the future.
Why is Demand for Bone Void Fillers Rising Fast in North America?
“Well-Developed Healthcare Infrastructure and High Prevalence of Bone Disorders”
Attribute | North America |
---|---|
Market Value (2024E) | US$ 1.42 Billion |
Growth Rate (2024 to 2034) | 5.8% CAGR |
Projected Value (2034F) | US$ 2.51 Billion |
The United States is estimated to account for 87% of the North American market in 2024. Bone void filler sales in Canada are projected to increase at a 6.3% CAGR from 2024 to 2034.
The prevalence of bone disorders and the number of orthopedic surgeries performed in the North American region are both increasing at a notable pace, which is creating opportunities for bone void filler companies in this region. The developed healthcare infrastructure in Canada and the United States has also been quick to adopt synthetic bone void fillers, thereby driving market growth as well.
The presence of key bone void filler distributors, an expanding geriatric population, rising cases of accidents and trauma, and the high availability of novel orthopedic surgeries and therapies are other factors that are projected to uplift bone void filler sales in the North American region over the next ten years and beyond.
Fact.MR, a market research and competitive intelligence provider, in this latest bone void filler market report, gives a detailed regional analysis of the industry with factors such as local supply, pricing trends, product standards, safety regulations, and new developments.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
Apart from North American countries, bone void filler suppliers should also invest in countries such as Japan, China, India, Australia, Germany, and Italy to diversify their business potential and boost global sales revenue going forward.
Why Should Bone Void Filler Suppliers Invest in Japan?
“Presence of Sizeable Geriatric Population with Bone Disorders”
Attribute | Japan |
---|---|
Market Value (2024E) | US$ 242.2 Million |
Growth Rate (2024 to 2034) | 8.2% CAGR |
Projected Value (2034F) | US$ 531.9 Million |
Japan is forecasted to account for 46.5% share of the East Asian market by 2034. Japan has one of the most sizeable senescent populations in the world. Aged people are more at risk of suffering from bone injuries and bone diseases such as osteoporosis, osteomyelitis, etc. The increasing use of bone void fillers to treat the aforementioned issues in geriatric people is predicted to offer money-making opportunities for bone void filler companies operating in Japan going forward.
What Makes European Countries Lucrative Markets for Companies?
“Increasing Approvals for Bone Void Filler Products”
European countries have been witnessing a steady hike in the number of osteoporosis cases and bone injuries in recent years. This trend is projected to primarily bolster bone void filler market sales in almost all European countries. Bone void filler companies from all parts of the world are focusing on improving their presence and product portfolio in Europe.
Regulatory authorities in the region are also approving novel bone void filler treatment products to promote healthy aging among Europeans in the future. Italy, Germany, Greece, France, and Finland are some noteworthy countries in this region that have a rapidly aging population, which could boost bone void filler demand in the region through 2034.
Category-wise Insights
Bone void filler suppliers are focusing on supplying demineralized bone matrix fillers in hospitals to maximize their revenue generation potential.
Which Type of Bone Void Filler is Most Widely Used?
“Extensive Use of Demineralized Bone Void Fillers Due to Shorter Recovery Times”
Attribute | Demineralized Bone |
---|---|
Segment Value (2024E) | US$ 1.44 Billion |
Growth Rate (2024 to 2034) | 4.8% CAGR |
Projected Value (2034F) | US$ 2.31 Billion |
Demineralized bone fillers are widely available with almost all key bone void filler companies around the world and this is what allows them to hold a significant bone void filler market share across the study period. Lower risk of complications and shorter recovery times associated with the use of demineralized bone fillers are also estimated to favor their demand on a global level in the future.
Which Factor is Responsible for High Bone Void Filler Use in Hospital Settings?
“High Investments in Healthcare Infrastructure Development and Establishment of New Hospitals”
Attribute | Hospitals |
---|---|
Segment Value (2024E) | US$ 1.84 Billion |
Growth Rate (2024 to 2034) | 5.6% CAGR |
Projected Value (2034F) | US$ 3.17 Billion |
A majority of orthopedic procedures are performed in hospitals and this is the prime factor driving up bone void filler demand in hospital settings. Increasing investments in healthcare infrastructure development are resulting in the establishment of new hospitals around the world, which is also estimated to favor sales of bone void fillers in this segment over the next 10 years and beyond.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Bone void filler manufacturers are focusing on launching new products and catalyzing the commercialization process of their regulatory-approved bone filler products. Product innovation is of the essence for any bone void filler company to stand out in the global marketplace.
- In March 2022, Molecular Matrix Inc., a renowned name in regenerative medicine, announced the commercial launch of its synthetic bone void filler that was cleared by the United States Food and Drug Administration (FDA) back in 2017. The Osteo-P® Synthetic Bone Graft Substitute features the company’s hyper-crosslinked carbohydrate polymer (HCCP) technology to optimize the regeneration and repair of bones.
- In January 2022, Bone Solutions Inc., a company focused on improving bone healing, announced the launch of its new injectable bone void filler. Mg OSTEOINJECT was the first-of-its-kind injectable bone void filler in the United States to include magnesium to support bone regeneration and bone repair.
Key Segments of Bone Void Filler Market Research
-
By Material:
- Demineralized Bones
- Calcium Sulfate
- Calcium Phosphate
- Tricalcium Phosphate
- Others
-
By Form:
- Putty
- Pastes
- Gels
- Granules
- Beads
- Sponges
- Strips
- Fibers
-
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
-
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
- FAQs -
How big is the bone void filler market in 2024?
The global bone void filler market is estimated at US$ 3.58 billion in 2024.
What is the demand outlook for bone void fillers?
Demand for bone void fillers is forecasted to reach a market valuation of US$ 6.03 billion by 2034-end.
At what rate is the global market forecasted to expand?
Sales of bone void fillers are projected to rise at 5.3% CAGR over the next 10 years.
Which region accounts for high sales of bone void fillers?
North America accounts for a leading 39.8% share of the global market in 2024.
What is a bone void filler used for?
Bone void fillers are used in orthopedic surgeries where bone remodeling or bone regeneration is required.
Who are the top bone void filler suppliers?
Stryker Corporation, Smith & Nephew plc, NuVasive® Inc., and Zimmer Biomet are leading bone void filler manufacturers in the world.